prevent the adverse pathology is also required. Our laboratory has used the mouse/C. muridarum model to show that, using the major outer membrane protein, MOMP as the vaccine candidate ... that underpin each type of…
altered B lymphocyte function. Our new analyses using the standard P. gingivalis oral gavage model to induce PD in lean mice demonstrates B lymphocytes play minor roles in PD bone ... human MIP-2 ortholog (IL-8), thus…
animal model compatible with chronic timescales. We have developed a model of chronic AIEC infection in five conventional mouse lines to study the host response and intestinal immunopathology following chronic
that likely activates CCP via a previously uncharacterized mechanism. Infection studies using mouse models indicated that BclA was recognized by C1q in vivo and that the interaction had biological consequences
factors, a protein microarray kit was customized for use with a mouse cecal ligation and puncture (CLP) model. Platelet-derived factors were detected by protein microarray analysis at different times
functional antibody responses, protect against viral challenge and prevent transmission in pre-clinical mouse and ferret models. This is the first report describing the induction of universal, broadly-reactive…
able to induce anti-tumor immunity against HPV associated tumors in a mouse model. The therapeutic efficacy of E7m was dramatically increased in its lipidated form. These results have successfully
boost antitumor immunity against tumor-associated antigens expressed on cancer cell membranes. Experiments using mouse models of cancers have shown that membrane- based cancer vaccines prepared by protein transfer…
responses in a manner consistent with licensing or education. Using both MCMV and influenza mouse models and tracking both resistance via viral titers and antigen-specific T cell responses
conjugate vaccines against MenX were developed at research scale and tested in pre- clinical mouse model. Following optimization of growth conditions of our seed MenX strain for capsular polysaccharide
current vaccines or therapeutics available. We analyzed five host-range CHIKV vaccines in a mouse model and assessed for joint swelling, generation of neutralizing antibodies, and protection from challenge
human populations of different endemic regions. The vaccine proved immunogenic and protective in a mouse model of visceral leishmaniasis. In studies with single and multiple vaccinations, agood safety profile
expressing Leishmania infantum LACK antigen has shown efficacy conferring protection in murine and canine models against cutaneous and visceral leishmaniasis. Until now, MVA, M65 and M101 are the only attenuated…
challenging, our protocol should be further used to study CCHFV infection in the knockout mouse model and virus neutralization assays in biosafety level 4 laboratories. PDF HTML
Ag85C, MPT51 and HspX (CMX) and evaluated its immunogenicity and protection in a murine model of infection. The stability of the vaccine in vivo was maintained up to 20 days ... vaccination. rBCG-CMX is highly…
usefulness as candidate immunogen for a broadly cross-reactive vaccine using a mouse RV infection model. Regions of the VP0 (VP4+VP2) capsid protein were identified as having high homology
inflammatory cytokines capable of controlling viral replication. NASVAC proved to be immunogenic in mouse models and then in phase I, II and III, randomized, double blinded and placebo controlled clinical
fundamental factor of the host-pathogen dynamics in an in-vivo mouse infection model. The method presented herein offers a generalizable approach to characterize infection at the single cell level
strain, the isolated Brevibacillus RRL-01, was speculated to be an uropathogen. An experimental mouse model was generated by transferring 2.5x108 cfu of the strain by trans-urethral catheterization
culture broth medium in the low nanomolar range and was efficacious in a mouse model of tuberculosis at a dose less than 1 mg per kg body weight, which highlights
treat clinical isolates. This strain diversification also occurs during in vivo infection in a mouse model, consistent with the fact that both coevolved phenotypes resemble strains commonly found in clinic
computational models for: (1) Genomewide discovery of alternative promoters in human and mouse genomes, (2) Modeling aberrant usage of alternative promoters in cancer genomes, and (3) Modeling the epigenetic…
requires a strong mucosal Th1 response together with mucosal antibodies. We have used a mouse model to evaluate different adjuvants and mucosal routes of vaccine delivery, combined with the major
built linker. The sMenC-TT conjugates when tested for immunogenicity in the mouse model, were found to elicit IgG and functional antibody titers comparable or better than those elicited
protected against a lethal challenge with antigenically distinct H1N1 A/PR8/34 in a mouse model. It was also shown that the adjuvanted vaccine gave a high level of protective
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.